Cargando…
Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
Chimeric antigen receptor (CAR) T-cell therapy engineers T-cells to express a synthetic receptor which redirects effector function to the tumor, to improve efficacy and reduce toxicities associated with conventional treatments, such as radiotherapy and chemotherapy. This approach has proved effectiv...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053711/ https://www.ncbi.nlm.nih.gov/pubmed/33883875 http://dx.doi.org/10.2147/BTT.S291768 |